Richard J. Mitrano - 05 Jul 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (KRRO)

Role: VP Finance & Operations
Signature: /s/ James Abely, Attorney-in-Fact for Richard Mitrano
Issuer symbol: KRRO
Transactions as of: 05 Jul 2022
Net transactions value: -$3,363
Form type: 4
Filing time: 07 Jul 2022, 16:53:27 UTC
Previous filing: 15 Apr 2022
Next filing: 19 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FREQ	Common Stock	Options Exercise		+7,500	+29%		33,179	05 Jul 2022	Direct	F1
transaction	FREQ	Common Stock	Sale	$3,363	-2,184	-6.6%	$1.54	30,995	06 Jul 2022	Direct	F2, F3
holding	FREQ	Common Stock						4,032	05 Jul 2022	The Carey/Mitrano Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FREQ	Restricted Stock Unit	Options Exercise		-7,500	-100%		0	05 Jul 2022	Common Stock	7,500		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2	Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
F3	This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.50 to $1.56. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F4	The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022.